These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8014033)

  • 1. Comparison between venoconstrictor effects of sumatriptan and ergotamine in migraine patients.
    Panconesi A; Anselmi B; Curradi C; Perfetto F; Piluso A; Franchi G
    Headache; 1994 Apr; 34(4):194-7. PubMed ID: 8014033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplifying effect of sumatriptan on noradrenaline venoconstriction in migraine patients.
    Panconesi A; Franchi G; Anselmi B; Curradi C; Tarquini B
    Cephalalgia; 1993 Dec; 13(6):383-8. PubMed ID: 8313451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contractile responses to sumatriptan and ergotamine in the rabbit saphenous vein: effect of selective 5-HT(1F) receptor agonists and PGF(2alpha).
    Cohen ML; Schenck K
    Br J Pharmacol; 2000 Oct; 131(3):562-8. PubMed ID: 11015308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs.
    Diener HC; Peters C; Rudzio M; Noe A; Dichgans J; Haux R; Ehrmann R; Tfelt-Hansen P
    J Neurol; 1991 Aug; 238(5):245-50. PubMed ID: 1655985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies.
    Cortijo J; Martí-Cabrera M; Bernabeu E; Domènech T; Bou J; Fernández AG; Beleta J; Palacios JM; Morcillo EJ
    Br J Pharmacol; 1997 Dec; 122(7):1455-63. PubMed ID: 9421295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man.
    Aellig WH
    Eur J Clin Pharmacol; 1983; 25(6):759-62. PubMed ID: 6662174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in the intensity of abortive migraine drug use during coumarin therapy.
    Rahimtoola H; Egberts AC; Buurma H; Tijssen CC; Leufkens HG
    Headache; 2001 Sep; 41(8):768-73. PubMed ID: 11576200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of migraine drugs on cerebral blood flow autoregulation.
    Vraamark T; Waldemar G; Paulson OB
    Cephalalgia; 1998; 18(6):306-12. PubMed ID: 9731933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venoconstrictor effect of dihydroergotamine in superficial hand veins.
    Aellig WH
    Eur J Clin Pharmacol; 1974; 7(2):137-9. PubMed ID: 4855381
    [No Abstract]   [Full Text] [Related]  

  • 10. Bovine isolated middle cerebral artery contractions to antimigraine drugs.
    Roon KI; Maassen Van Den Brink A; Ferrari MD; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):591-6. PubMed ID: 10598799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced serotonin vascular sensitivity in ergotamine abusers.
    Panconesi A; Franchi G; Del Bianco PL; Anselmi B; Andreini R; Sicuteri F
    Cephalalgia; 1989 Dec; 9(4):259-64. PubMed ID: 2611883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT receptors mediating contractions of the isolated human coronary artery.
    Bax WA; Renzenbrink GJ; Van Heuven-Nolsen D; Thijssen EJ; Bos E; Saxena PR
    Eur J Pharmacol; 1993 Aug; 239(1-3):203-10. PubMed ID: 7693489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of peripheral serotonergic receptors in migraine and cluster headache by sumatriptan.
    Martelletti P; Stirparo G; Rinaldi C; Giacovazzo M
    Int J Clin Pharmacol Res; 1994; 14(5-6):165-75. PubMed ID: 7672873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of migraine: a tentative synthesis.
    Lance JW
    Pathol Biol (Paris); 1992 Apr; 40(4):355-60. PubMed ID: 1379708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary side-effect potential of current and prospective antimigraine drugs.
    MaassenVanDenBrink A; Reekers M; Bax WA; Ferrari MD; Saxena PR
    Circulation; 1998 Jul; 98(1):25-30. PubMed ID: 9665056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
    Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
    Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study.
    Evers S; Gralow I; Bauer B; Suhr B; Buchheister A; Husstedt IW; Ringelstein EB
    Clin Neuropharmacol; 1999; 22(4):201-6. PubMed ID: 10442248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
    Aellig WH
    Cardiology; 1976; 61 suppl 1():302-8. PubMed ID: 975144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan.
    den Boer MO; Villalón CM; Heiligers JP; Humphrey PP; Saxena PR
    Br J Pharmacol; 1991 Feb; 102(2):323-30. PubMed ID: 1849764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
    Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.